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Genetics of depressive symptoms in
adolescence
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George Davey Smith1 and Lavinia Paternoster1
Abstract
Background: Despite many attempts to understand the genetic architecture of depression, little progress has been
made. The majority of these studies, however, have been carried out in adults and do not account for the potential
influence of development.
Methods: The Avon Longitudinal Study of Parents and Children (ALSPAC) is a longitudinal pregnancy cohort which
recruited participants between April 1991 and December 1992. Analyses were replicated in two independent
European cohorts. Genome-wide complex trait analysis (GCTA) software was used to investigate SNP-heritability
(h2SNP) of depression across adolescence, the role of puberty was investigated by stratifying these estimates
according to pubertal onset. Genome-wide association studies were performed to identify genetic variants
associated with depression at different stages of development.
Results: Heritability was estimated between the ages of 11 and 18 with sample sizes ranging from 3289 to 5480.
Heritability was low with an apparent peak was found at age 13 (h2 = 0.17, p = 0.006). Confidence intervals around
these estimates suggest an upper-bound to h2SNP of around 30%. A variant located on chromosome 7 was found to
be associated with depressive symptoms at age 13 in ALSPAC (rs138191010: β = 0.142, p = 2.51 × 10−8), although
this was not replicated.
Conclusions: Although power is a potential limitation, the observed patterns provide interesting hypotheses
surrounding the heritability of depression at different developmental stages. We found substantially lower estimates
for depressive symptoms at age 11 (0.07) compared to those previously estimated in adults (0.21). We also found a
peak in heritability at age 13. These findings suggest environmental factors are likely to be more important in the
aetiology of depressive symptoms in early adolescence than in adulthood.
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Background
Despite many attempts to understand the genetic architec-
ture of depression, progress has been slow, particularly
when compared with other complex disorders. The Psychi-
atric Genomics Consortium (PGC) recently identified 108
risk loci for schizophrenia [1], whereas corresponding ana-
lyses performed for major depressive disorder (MDD) failed
to find any robustly associated loci [2]. More recently,
however, studies have utilised data from the UK Biobank
and 23andMe which resulted in discovery samples of over
100,000 participants of European ancestry [3, 4]. The
China, Oxford and Virginia Commonwealth University
Experimental Research on Genetic Epidemiology (CON-
VERGE) consortium applied sparse whole genome sequen-
cing to a sample of over 5000 cases of major depression
and 5000 controls amongst Han Chinese women [5]. These
studies report finding several genetic variants associated
with depressive symptoms measured in adults.
Both phenotypic and/or genetic heterogeneity may con-
tribute to the slow progress in identifying genetic loci ro-
bustly associated with depression [6]. Work has focused
on dissecting the phenotype, with studies focusing on age
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at onset or subgroups including early onset or recurrent
depression, in an attempt to understand the genetic archi-
tecture [6–8].
Heritability is the proportion of variation in a pheno-
type attributable to genetic differences. A meta-analysis
of twin studies estimated the heritability of MDD in
adults to be 0.37 (95% CI: 0.31, 0.42) [9], while recent
work by the PGC used SNP-based methods imple-
mented by the Genome-wide Complex Trait Analysis
(GCTA) software [10] to estimate a common SNP-
heritability (h2SNP) of 0.21 [11]. Although these estimates
may at first appear inconsistent, the estimate from twin
studies is expected to be higher as they take into account
variation across the entire genome, whereas h2SNP esti-
mates incorporate only common variants captured by
SNPs included on genotyping platforms.
The majority of these studies of depression have been
carried out in adults. However, a recent publication by
Nivard et al. [12] investigated symptoms of anxiety and
depression across the lifecourse using data from the
Netherlands Twin Registry (NTR), suggesting heritability
might vary according to age. The study combined data
from 49,524 twins whose ages ranged from 3 to 63. Her-
itability estimates calculated in this study showed fluctu-
ations from early life until the early 20s (highest at 0.69,
aged 3), after age 20 heritability remained relatively
stable at around 0.5.
Nivard et al. [12] found a substantial genetic compo-
nent to childhood depression, with a distinct drop in
heritability from 0.58 to 0.37 at age 12. Estimates in-
creased again throughout adolescence and reached a
peak of 0.53 at age 18. This is an interesting contrast to
findings from many other twin studies which suggest a
minor genetic component to depression in early life and
increasing heritability with age, the heritability in late
adolescence being comparable with that of adult depres-
sion [13–17]. However, the drop in heritability found in
the Nivard study might be confounded by a switch in
reporting method, as depression measures switched
from parent- to self-reported questionnaires.
In addition to coinciding with a switch in reporting
method, the timing of this change in heritability is inter-
esting as it coincides with pubertal onset. At age 12,
many participants are likely to be nearing the onset of
puberty, if they have not entered it already. Pubertal sta-
tus and depression are highly associated, with a 1 year
prevalence of depression of around 1% in pre-pubertal
children, rising to 4–5% in mid to late adolescence [18].
Prior to puberty the prevalence of depression is similar
in both males and females, however after pubertal onset
this rises more rapidly among females. This has
prompted some to hypothesise that changes during pu-
berty, or the timing of pubertal onset, could be related
to the onset of depressive symptoms [19–21]. Although
mechanisms are unclear, biological theories suggest earl-
ier puberty and the hormonal changes associated with
this, such as increasing levels of dehydroepiandrosterone
(DHEA), may act as a trigger for some underlying vul-
nerability [22, 23]. Alternatively, psychosocial theories
hypothesise that depression is a social consequence of
the early onset of puberty compared to peers [24].
We aim to investigate patterns of heritability across
adolescence using data from the Avon Longitudinal
Study of Parents and Children (ALSPAC), which has
both parent- and self-reported measures of depressive
symptoms available at regular intervals during this im-
portant developmental period.
ALSPAC is a prospective birth cohort started in the
early 1990s, which holds information on a number of
measures, including depression and pubertal status. This
includes a combination of parent- and self-reported de-
pression measures at a variety of time points, which en-
abled us to investigate the change in heritability found
by Nivard et al. [12]. Genotyping data are available on a
large number of ALSPAC participants, enabling us to es-
timate h2SNP directly at different ages using restricted
maximum likelihood (REML) methods and to attempt to
identify genetic variants associated with depression mea-
sures across a range of ages.
Methods
Avon longitudinal study of parents and children (ALSPAC)
ALSPAC is a longitudinal pregnancy cohort which aimed
to recruit all pregnant women in the former county of
Avon with an expected due date between April 1991 and
December 1992. Detailed information has continued to
be collected on mothers, partners and children in the
cohort, this process has been described in detail else-
where [25, 26]. Ethical approval for the study was ob-
tained from the ALSPAC Ethics and Law Committee
and the Local Research Ethics Committees. A fully
searchable data dictionary with information on all avail-
able measures is available at http://www.bris.ac.uk/
alspac/researchers/data-access/data-dictionary/.
Depression measures
Symptoms of depression in the ALSPAC children were
measured throughout childhood and adolescence using a
combination of both parent- and self-reported responses
to the Short Moods and Feelings Questionnaire (SMFQ)
[27]. The SMFQ consists of 13 phrases relating to the
feelings and actions of participants in the previous
2 weeks, which they are asked to rate as ‘most of the
time’, ‘some of the time’ or ‘not at all’ (scoring 2,1 or 0,
respectively). A higher score on the SMFQ corresponds
to a greater level of depressive symptoms.
Timing of SMFQ measurements is described in detail
in Additional file 1: Materials and Methods. For the
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purposes of these analyses and to avoid bias from shift
in reporting, we focus on self-reported responses.
Pubertal status
Pubertal status was regularly measured in ALSPAC, be-
tween 7.5 to 18 years. Tanner Stages were used to meas-
ure pubertal stage in both males and females [28, 29]. In
this analysis we have used the Tanner Stage correspond-
ing to pubic hair development for both males and fe-
males to assess pubertal onset.
Further details on the derivation of pubertal onset are
described in Additional file 1: Materials and Methods.
Genotyping and GRM
Directly genotyped data were available on 8237 children
and 477,482 SNPs. A genetic relatedness matrix (GRM)
was estimated for this sample. Full details can be found
in Additional file 1: Materials and Methods.
Statistical analysis
Calculating h2SNP
h2SNP was calculated using the REML method imple-
mented within the GCTA software [10]. Estimates of
heritability were calculated and plotted for each age at
which we had a self-reported measure of depressive
symptoms. Given our interest in investigating whether
there is a drop in heritability around puberty as seen in
Nivard et al. [12], we focused on ages 11, 13, and 18. In
addition to estimating h2SNP at each of these ages, we
performed exploratory analyses stratified by sex and also
pubertal status when participants were aged 11 and 13.
For each of our h2SNP estimates, analyses were adjusted
for age. Where analyses were performed on the overall
sample, we also adjusted for sex.
As a sensitivity analysis, we re-calculated h2SNP esti-
mates for our main ages of interest, restricting to partici-
pants with data on pubertal status. Given that the
distribution of SMFQ scores varied according to age, we
also applied a quantile normal transformation and used
these transformed scores in the analysis.
Power calculations were performed for our analyses
using the GCTA-GREML power calculator available at
http://cnsgenomics.com/shiny/gctaPower/ [30].
Genome-wide association analysis (GWAS)
Genome-wide association analyses were carried out for
self-reported depressive symptoms at ages 11, 13, and 18
and performed using SNPTEST v2.5 [31]. Analyses were
adjusted for age and sex. Both the REML and GWAS
analyses were restricted to participants of a European
ancestry.
Replication
A look up of any SNP achieving genome-wide signifi-
cance (p < 5 × 10−8) in this analysis was performed in
both the TRacking Adolescents’ Individual Lives Survey
(TRAILS) [32, 33] and the Twins Early Development
Study (TEDS) [34]. Information on both cohorts can be
found in Additional file 1: Materials and Methods.
Results
The number of ALSPAC participants with complete infor-
mation on both depression and genotype ranged from
5480 at age 11 to 3289 at age 18 (those also with puberty
data were lower, 3759 and 1724 at 11 and 18, respectively).
There were slightly more females than males and this in-
creased slightly with age, (49.4% males at age 11 reducing
to 43.0% at 18, Table 1).
Proportion of participants in the pre-pubertal category
differed according to sex. At ages 10 and 13, there were
a greater proportion of females who had experienced the
onset of puberty compared with males (p < 0.001 in both
cases, Table 1). The proportion of the overall sample
reaching onset increased from 37.3% at age 10 to 92.6%
at age 13. By the time the sample was aged 18, 99% of
participants reported onset of puberty.
Estimating h2SNP
Overall sample
h2SNP estimates of child self-reported SMFQ ranged from
2% to 17%, with a peak around age 13 (h2 = 0.17,
Table 1 Sample Characteristics
Age 11
(N = 5480)
Age 13
(N = 5055)
Age 18
(N = 3289)
Mean age in months (SD) 127.7 (3.02) 153.6 (2.73) 213.9 (4.43)
Males N (%) 2706 (49.4) 2462 (48.7) 1414 (43.0)
SMFQ score (LQ-UQ)1 3 (1–6) 3 (1–5) 5 (3–9)
Subset with puberty data - N 3759 3147 1724
Puberty – number post-onset (%) Overall 1402 (37.3) 2913 (92.6) 1723 (99.9)
Male 525 (31.9) 1240 (88.5) 675 (100.0)
Female 877 (41.5) 1673 (95.8) 1048 (99.9)
1 Median child reported SMFQ score with lower and upper quartiles reported due to skew in score
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p = 0.006) (Fig. 1, Table 2). However standard errors for
these estimates are large and overlapping, with only the
estimate at age 13 showing robust evidence for a non-
zero h2SNP. The pattern is consistent across both parent-
and self-reported measures, although parent-reported
measures suggested lower estimates of h2SNP at compar-
able time points (Figs 1 and Additional file 1: Fig. S1).
Given our interest in investigating the pattern of effects
found by Nivard et al. [12], we focus on self-report data
from 3 time points – ages 11, 13 and 18.
Stratified by sex
When we perform exploratory sex-stratified analysis, the
h2SNP peak occurs at age 13 in males (h
2 = 0.30,
p = 0.020), but at 18 in females (h2 = 0.18, p = 0.286),
whereas the h2SNP estimates for males at age 18 and fe-
males at 13 are close to zero (Table 2). However, stand-
ard errors for these estimates are large and overlapping.
If real, these differences might be explained by differ-
ences in pubertal timing of males and females, we there-
fore investigated the effect of puberty on h2SNP estimates.
Stratified by puberty
To investigate whether pubertal timing could explain the
differences in h2SNP estimates at different times in males
and females we performed exploratory analysis stratified
according to pre- and post-onset of puberty.
When we stratify the results by pubertal stage, at age
11 we see increased heritability among males post-onset
(h2 = 0.81, p = 0.156) and females pre-onset (h2 = 0.39,
p = 0.134); a similar pattern is seen at age 13 (Table 2).
However, the sample sizes in these stratified analyses are
small, resulting in large standard errors and thus results
should be interpreted with caution.
We investigated whether timing of puberty had an ef-
fect on h2SNP by adjusting the female estimates for age at
Fig. 1 Heritability estimates of depressive symptoms measured during childhood and adolescence in NTR and ALSPAC
Table 2 Heritability estimates of child-reported SMFQ scores at the main ages of interest1
Age 11 Age 13 Age 18
N h2
(se)
P-value N h2
(se)
P-value N h2
(se)
P-value
Overall sample 5480 0.07 (0.06) 0.244 5055 0.17 (0.06) 0.006 3289 0.03 (0.10) 0.712
Male 2706 0.04 (0.12) 0.760 2462 0.30 (0.13) 0.020 1414 <0.001 (0.22) 1.000
Female 2774 0.07 (0.12) 0.570 2593 0.03 (0.12) 0.790 1875 0.18 (0.17) 0.286
Stratified by puberty
Male Pre 1123 <0.001 (0.28) 1.000 161 0.05 (1.96) 0.980 - -
Post 525 0.81 (0.59) 0.156 1240 0.43 (0.27) 0.108 - -
Female Pre 1234 0.39 (0.26) 0.134 73 1.00 (4.28) 0.784 - -
Post 877 0.11 (0.37) 0.758 1673 0.10 (0.19) 0.592 - -
1 All analysis adjusted for age (in months), overall sample additionally adjusted for gender
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both assessment and menarche. The pattern of estimates
remained relatively consistent, with the majority of esti-
mates becoming larger after controlling for age at me-
narche (Additional file 1: Table S1).
Sensitivity analysis
Complete case analysis
When we re-estimated overall h2SNP at each of our ages
of interest using only participants with complete data
(i.e. pubertal stage), the estimates for ages 11 and 13 be-
came smaller (<0.1% and 4.1% respectively), while h2SNP
at age 18 remained of a similar level (3.3%). However,
the number of participants in the younger age groups
was substantially reduced, those with data available at
age 18 remained similar.
Transformed data
Given that the SMFQ data were somewhat skewed, and
the skew appeared to increase with age (Additional file 1:
Fig. S2), we applied a quantile normalisation transform-
ation at each age. The pattern of heritability estimates
remained relatively constant. Of our 3 main ages of inter-
est, we saw a slight increase in estimated heritability at age
11 and 18 (0.08 and 0.1 respectively), the peak seen at 13
remained (h2 = 0.15) (Additional file 1: Table S2).
Genome-wide association studies
A genome-wide association study (GWAS) was per-
formed for each of our ages of interest. At age 11 and
age 18 we found no variants achieving genome-wide sig-
nificance levels (p ≤ 5 × 10−8). At age 13, however, we
found evidence of an association between a well-
imputed (information score = 0.88) variant on chromo-
some 7 (rs138191010 – risk allele: T, β = 0.142, se = 0.03,
p = 2.51 × 10−8) and depressive symptoms (Fig. 2, Add-
itional file 1: Fig. S3). Sex-stratified analyses found no
robust associations, although the direction of effect with
rs138191010 was consistent (Females: β = 0.134, se = 0.04,
p = 1.38 × 10–4; Males: β = 0.150, se = 0.04,
p = 5.71 × 10−5). There was also no strong evidence of
an association between rs138191010 and depressive
symptom scores at either age 11 or 18, however the
Fig. 2 Manhattan plot showing associations from GWAS of SMFQ at 13 years
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direction of effect was consistent across all time points
(Age 11: β = 0.065, se = 0.03, p = 0.009; Age 18: β = 0.062,
se = 0.03, p = 0.054).
A sensitivity analysis using quantile normalised scores
at age 13 found strong evidence of an association
(β = 0.135, se = 0.03, p = 6.7 × 10−8).
A look up of this variant in both the TRAILS and TEDS
cohorts failed to replicate the finding (Additional file 1:
Fig. S4).
Discussion
This study aimed to build on work by Nivard et al. [12]
by attempting to unpick the heritability of depression
across adolescence and investigating the role of puberty.
Unlike the Nivard study, which found that heritability
decreased substantially at age 12, our estimates, although
lower, appeared to peak close to this time at age 13
(h2twin: 0.37 vs h
2
SNP:0.17). Although Nivard et al. [12] of-
fered several explanations for this, including puberty,
they noted that it coincided with a switch in question-
naires from parent to self-report, acknowledging that the
decrease may be an artefact of the change in reporting
method.
Nivard et al. [12] found increased heritability estimates
when using parent-reported depressive symptoms, how-
ever, in ALSPAC these estimates were consistently lower
than for self-reported symptoms. Regardless of rater, and
in both raw and transformed data, we found a peak in
heritability around age 13. With raters only overlapping
at one time point, it seems likely that the drop in herit-
ability seen in the Nivard paper is related to change in
reporting method.
Within ALSPAC both parent and self-reported depres-
sive symptoms are available, enabling us to remove this
source of confounding from estimates, however, con-
founding according to timing of puberty remains. We in-
vestigated this by stratifying on pubertal status, enabling
us to explore patterns of heritability according to age
and pubertal status. However, our sample size was re-
duced somewhat when running these exploratory ana-
lyses and restricting to those with data on puberty, and
no firm conclusions could be made.
We dichotomised pubertal stage into pre- and post-
pubertal onset according to Tanner stage. At age 11
around 30% of males had reached puberty, compared to
approximately 40% of females. At this age, heritability
estimates were highest among males who had reached
puberty (h2 = 0.81, p = 0.156) and pre-pubertal females
(h2 = 0.39, p = 0.134). Given that males generally experi-
ence puberty later than females, it is possible that these
differences in heritability are related to differences in
timing of puberty and changes in environmental rather
than genetic risk. One explanation would be that the so-
cial consequences of earlier puberty are opposite for
males and females, with earlier puberty being protective
in boys reducing environmental risk and thereby in-
creasing the relative contribution of genetic risk. While
earlier puberty could increase environmental risk in fe-
males, hence reducing the relative contribution of gen-
etic risk at this age.
When stratifying analyses on sex, regardless of pubertal
status, heritability was increased for males at age 13
(h2 = 0.30) and females at 18 (h2 = 0.18). This increased
male estimate appears to be driving the overall peak in
heritability (h2 = 0.17) at 13, although a sex-stratified
GWAS found no SNPs achieving genome-wide
significance.
We had good power when using the entire sample
(power at age 11:84%; 13:78%; 18:42%) to detect a true
heritability of 17%. Despite little statistical evidence for
non-zero heritability at most ages, the confidence inter-
vals estimated for age 11 exclude 21%, suggesting that
our results demonstrate h2SNP at this age is lower than
that previously reported for adult depression. Though
this could be explained by phenotype definition, rather
than biological differences per se, as we used self-
reported measures of depressive symptoms rather than
detailed diagnostic interviews. When performing strati-
fied analyses, power will be diminished further, however,
the pattern of results observed generate interesting hy-
potheses that could be followed up in larger datasets.
While Nivard et al. [12] found high heritability esti-
mates among their younger age groups, estimates at age
11 in our study do not overlap with these. However, it is
important to remember SNP-based and twin heritability
are different. We would expect twin estimates to be
higher simply due to the study design, which relies on
closely related individuals. Some of this inflation in h2 is
real, due to shared rare genetic variants, whereas some
is due to shared common environment, and therefore
false inflation of the estimates. Our analyses are re-
stricted to unrelated individuals in an attempt to prevent
inflation of our h2SNP estimates due to shared environ-
ment. Additionally, our analyses incorporate only vari-
ants captured on the genotyping platform used, and is
an estimate of the heritability we could potentially esti-
mate through GWAS.
Although we expect to see higher estimates from
Nivard et al. [12] in general, we can compare the pat-
terns of heritability across time in the two studies.
Nivard et al. [12] report a decline in heritability during
childhood and adolescence, however the results shown
in ALSPAC do not support this. Our results are rela-
tively stable from age 11–18, with the exception of a
peak at around age 13.
It is also important to consider selective drop out when
thinking about these patterns of heritability. Those with
increased depressive symptoms may be more likely to
Sallis et al. BMC Psychiatry  (2017) 17:321 Page 6 of 8
drop out, leading to declines in heritability. However, no
robust evidence of association between a genetic risk score
for depression and dropout was found in our sample
(p = 0.67).
A GWAS in ALSPAC found evidence of association be-
tween a variant on chromosome 7 (rs138191010) and de-
pressive symptoms at age 13 (when we also see greatest
heritability). However, this was not replicated in TRAILS
(which found weak evidence of an association in the op-
posite direction) or TEDS (which found no robust evi-
dence of an association). Both ALSPAC and TEDS used
the SMFQ to assess depression, while the Youth Self Re-
port was used in TRAILS. When restricting to just
ALSPAC and TEDS, which used a consistent measure of
depression, there remained no strong evidence of an asso-
ciation. It is therefore possible that this is a false positive.
Limitations
Although our analyses, in particular those stratifying on
pubertal status, may lack power, the patterns observed
provide interesting hypotheses surrounding the heritabil-
ity of depression at different developmental stages, and
provide pilot data that can be utilised to design well-
powered studies to investigate these hypotheses.
Conclusion
We estimated heritability of depression at several points
through late childhood and across adolescence and found
an apparent peak in heritability at age 13, confidence in-
tervals around the heritability estimates throughout these
ages suggest an upper-bound to h2SNP of around 30%. Our
results indicate that sex and pubertal onset are likely to
affect heritability estimates. We also found differences be-
tween previous h2SNP estimates calculated in adults (0.21)
and our lower estimates for depressive symptoms found at
age 11 (0.07). A variant located on chromosome 7 was
found to be associated with depressive symptoms at age
13 in ALSPAC, although this was not replicated in other
European studies.
Additional file
Additional file 1: This file contains Additional materials and methods,
Tables S1-S2 and Figs. S1-S3. (DOCX 0.99 mb)
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